Multimodal Data
Data Solutions for Biopharma
Caris Life Sciences is at the forefront of a data-led revolution in personalized cancer care. In partnership with biopharma innovators, Caris is shaping the future of precision oncology by developing groundbreaking solutions that deliver powerful outcomes. By combining advanced molecular science and artificial intelligence (AI) with years of experience and a world-class database comprised of both whole exome and whole transcriptome sequencing, Caris generates actionable insights to help accelerate the development of new medicines and diagnostics.
DOCUMENT DOWNLOADS
Caris Biopharma Brochure
Biopharma Dealmakers Article
Biopharma Data Overview
Data Without Context is Incomplete
Caris is the industry leader when it comes to case volume combined with breadth and depth of multimodal data – the combination of molecular, claims, and real-world data:
- Molecular data spanning more than 550,000 matched clinico-genomic profiles and across 57 indications
- Real-world claims data through partnerships to enable the ability to see deeper into patient journey than ever before
- H&E Images, Digital Pathology
- Algorithm and Signature development
DNA/RNA landscaping
WES & WTS
Mapping the tumor microenvironment (TME)
Repository of unstained FFPE slides
Connecting biology to clinical care
- 550K+ matched genomic profiles with claims data
- Deeply curated EHR through multiple clinical linkages
Identify ideal patient populations
Molecular data
Total Case Volume
748,000+
Whole Exomes
397,000+
Whole Transcriptomes
449,000+
tissue & protein
Total Pathology Slides
18+ Million
H&E and IHC Digitized Slides
3.9+ Million
Total Image Features Captured
162+ Billion
multimodal data
Matched Clinico-Genomic Profiles
550,000+
EHR Partners
3+
Tumor Types
57
ai & innovation
Digital Pathology Algorithms for Biomarkers
26*
Clinical Signatures
2
*Includes in development
Big Data, Bigger Impact
Discover
More
The fundamental understanding of disease at the molecular level is the essence of precision medicine.
Unlock truly novel and otherwise inaccessible targets for your discovery pipeline with Caris Discovery.
Get Answers from Caris Biopharma
"*" indicates required fields